Toshifumi Sugatani
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease. (.pdf)
Vaught DB, Merkel AR, Lynch CC, Edwards J, Tantawy MN, Hilliard T, Wang S, Peterson T, Johnson RW, Sterling JA, Brantley-Sieders D.
JBMR Plus. 2021 Mar 9;5(4):e10465.
This meeting is virtual and in-person. The in-person location is BJC Institute of Health, 11th floor, conference room AB. Virtual is by Zoom. Please email Christina Grantham (granthamc@wustl.edu) for Zoom meeting information.